Calton & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Buy |
+1,952
| New | +$216K | 0.04% | 352 |
|
|
2021
Q4 | – | Sell |
-3,958
| Closed | -$276K | – | 378 |
|
|
2021
Q3 | $276K | Sell |
3,958
-204
| -5% | -$14.2K | 0.06% | 304 |
|
|
2021
Q2 | $287K | Buy |
4,162
+633
| +18% | +$43.7K | 0.05% | 308 |
|
|
2021
Q1 | $228K | Sell |
3,529
-92
| -3% | -$5.94K | 0.04% | 350 |
|
|
2020
Q4 | $211K | Sell |
3,621
-1,996
| -36% | -$116K | 0.04% | 357 |
|
|
2020
Q3 | $355K | Buy |
5,617
+1,022
| +22% | +$64.6K | 0.07% | 208 |
|
|
2020
Q2 | $354K | Sell |
4,595
-2,646
| -37% | -$204K | 0.08% | 196 |
|
|
2020
Q1 | $541K | Sell |
7,241
-1,435
| -17% | -$107K | 0.13% | 136 |
|
|
2019
Q4 | $564K | Buy |
8,676
+1,588
| +22% | +$103K | 0.11% | 159 |
|
|
2019
Q3 | $449K | Sell |
7,088
-397
| -5% | -$25.1K | 0.1% | 168 |
|
|
2019
Q2 | $506K | Sell |
7,485
-465
| -6% | -$31.4K | 0.14% | 124 |
|
|
2019
Q1 | $517K | Sell |
7,950
-401
| -5% | -$26.1K | 0.16% | 125 |
|
|
2018
Q4 | $522K | Sell |
8,351
-30
| -0.4% | -$1.88K | 0.19% | 105 |
|
|
2018
Q3 | $647K | Sell |
8,381
-6
| -0.1% | -$463 | 0.19% | 99 |
|
|
2018
Q2 | $645K | Sell |
8,387
-1,684
| -17% | -$130K | 0.19% | 92 |
|
|
2018
Q1 | $759K | Buy |
10,071
+307
| +3% | +$23.1K | 0.22% | 94 |
|
|
2017
Q4 | $790K | Buy |
+9,764
| New | +$790K | 0.2% | 93 |
|